New cancer drug IPH4502 enters first human tests
Disease control
Recruiting now
This early-stage trial is testing a new drug called IPH4502 in people with advanced solid tumors that have a specific protein called Nectin-4. The main goals are to check the drug's safety and find the best dose. About 145 participants will receive the drug, and researchers will …
Phase: PHASE1 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC